Entrectinib use in a platinum-refractory mucinous ovarian cancer harboring a NTRK3 gene fusion
Ovarian cancer is difficult to treat, and the mucinous epithelial subtype has a particularly poor response to traditional chemotherapy regimens. Entrectinib is a tumor-agnostic tyrosine kinase inhibitor with limited data regarding its use in ovarian cancers, though it demonstrates significant tumor...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2023-06-01
|
| Serie: | Gynecologic Oncology Reports |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2352578923000565 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|